2,521
edits
Difference between revisions of "Enzymatic processes"
→NovelYeast bv
Lars Krause (talk | contribs) |
Lars Krause (talk | contribs) |
||
| Line 123: | Line 123: | ||
=== NovelYeast bv === | === NovelYeast bv === | ||
{{Infobox provider-enzymatic processes|Company=NovelYeast bv|Processable volume=5|Feedstock=1G and 2G feedstocks|Other=Application of commercial enzyme cocktails, development of in situ enzyme production|Temperature=25-60|Safety restrictions=Standard microbiological practice|Reactor material=Glass|Reactor=Shake flasks, static tubes with magnetic stirring|Controlled paramaters=Standard parameters|Webpage=https://www.linkedin.com/in/johan-thevelein-aab60a10/| | {{Infobox provider-enzymatic processes|Company=NovelYeast bv|Processable volume=5|Feedstock=1G and 2G feedstocks|Other=Application of commercial enzyme cocktails, development of in situ enzyme production|Temperature=25-60|Safety restrictions=Standard microbiological practice|Reactor material=Glass|Reactor=Shake flasks, static tubes with magnetic stirring|Controlled paramaters=Standard parameters|Webpage=https://www.linkedin.com/in/johan-thevelein-aab60a10/|Agitator=Shake flasks, magnetic stirring|Capacity=Lab scale|TRL=3-5|Technology category=Enzymatic saccharification|Technology name=Enzymatic saccharification, In-situ enzyme production|Contact=johan.thevelein@novelyeast.com|Country=Belgium|Product=Fermentable sugars}} | ||
NovelYeast bv was founded in 2019 by Prof. Johan Thevelein (KU Leuven and VIB) to continue his R&D activities after his retirement in 2020 as emeritus. The company focusses on the development and industrial implementation of yeast cell factories for the production of biofuels, bio-based chemicals as well as specialty sugars and ingredients with first- and second-generation feedstocks. It also develops cell factories for the production of specific proteins for food applications and enzymes for saccharification of lignocellulosic biomass. In addition, it uses yeast as a tool for biomedical and agroindustrial applications, including yeast probiotics and anti-cancer drugs selected by screening in yeast. NovelYeast has several R&D service collaborations with companies world-wide. | NovelYeast bv was founded in 2019 by Prof. Johan Thevelein (KU Leuven and VIB) to continue his R&D activities after his retirement in 2020 as emeritus. The company focusses on the development and industrial implementation of yeast cell factories for the production of biofuels, bio-based chemicals as well as specialty sugars and ingredients with first- and second-generation feedstocks. It also develops cell factories for the production of specific proteins for food applications and enzymes for saccharification of lignocellulosic biomass. In addition, it uses yeast as a tool for biomedical and agroindustrial applications, including yeast probiotics and anti-cancer drugs selected by screening in yeast. NovelYeast has several R&D service collaborations with companies world-wide. | ||